focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Start of digital plaster pilot

1 Nov 2012 07:00

RNS Number : 0301Q
Toumaz Limited
01 November 2012
 



1 November 2012

 

Toumaz Limited

 

Major hospital pilot deployment of Toumaz's wireless plaster to monitor vital signs underway

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low cost, ultra-low power wireless technology, has started to pilot its digital vital signs plaster, SensiumVitals, in a major US hospital. 

 

The SensiumVitals monitor is a disposable, ultra-thin plaster which continuously monitors the patient's heart rate, respiratory rate and temperature whilst in hospital. This significantly increases patient surveillance compared to current practice, which involves manual measurement of vital signs every six to eight hours.

 

The device, which also has an alert capability, enables patients to be fully mobile whilst being monitored, so helping to promote patient morale and recovery. SensiumVitals is targeted at the general wards of hospitals which account for the vast majority of hospital beds, unlike traditional, bulky, wired monitoring products which are usually only found in hospital intensive care units.

 

SensiumVitals also provides hospitals with significant cost-savings as continuous monitoring can reduce the number of patients who have to be admitted or readmitted to costly intensive care, as any deterioration in condition can be alerted and dealt with immediately.

In the US alone, wireless vital signs monitoring devices are forecast to reduce healthcare costs by around $200 billion over the next 25 years. (Center for Technology and Aging Report, May 2010).

The pilot is being carried out at St. John's Health Centre in Santa Monica, California, by Toumaz US, the Group's US joint venture with Dr Patrick Soon-Shiong's company, NantWorks.

 

Anthony Sethill, CEO of Toumaz, commented:

 

"This pilot is a major milestone for the Group as we start to commercialise our low cost, ultra-low power wireless technologies for use in the medical markets.

 

 "This disruptive wireless monitoring technology is the world's first FDA cleared and fully disposable vital signs monitoring solution for general use in hospitals. SensiumVitals represents a breakthrough in how patient care is delivered, setting a new, cost effective standard for hospitals and also benefitting patients' recovery.

 

"Early feedback from patients and hospital staff has been very positive with the device detecting deterioration in patients' conditions instantaneously, enabling intervention much sooner than normal."

 

Michael Trevino, CTO of NantHealth, a NantWorks company, commented:

 

"At NantWorks we believe continuous patient monitoring in the hospital will one day be standard practice and this will be enabled by foundational technology like SensiumVitals, delivered by Toumaz US. Continuously streamed patient data automatically flowing into hospital information systems will drive the right care at the right time and in the right place."

  

Enquiries:

 

Toumaz

+44 (0)1235 438950

Anthony Sethill, Chief Executive Officer

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Daniel Harris

College Hill (Financial PR)

+44 (0)20 7457 2020

Adrian Duffield/Rozi Morris

 

About SensiumVitals

 

The SensiumVitals digital plaster is a fully disposable device, with smart sensor interface and transceiver, aimed at the general wards of hospitals. The device continuously monitors patients' vital signs (heart-rate, respiration rate & temperature) and wirelessly communicates this data to doctors and nurses via the hospital's IT system.

 

Currently, the majority of patients in hospital have measurements of vital signs taken manually at six to eight hour intervals. This relatively infrequent monitoring means that deterioration in patient conditions may go unnoticed, leading to further treatment or re-admittance to intensive care units.

 

The SensiumVitals monitor is a disposable ultra-thin plaster that is attached to patients under their clothing. The device enables the patient to be completely ambulatory and still be monitored.

 

Hospital staff can set up alerts that can be sent to pagers/handheld devices to warn them of patient deterioration. This enables caregivers to prioritise patients based on their condition. SensiumVitals has a battery life of five days, covering the average length of a general ward stay in the hospital. At the end of a patient's stay the entire device can be disposed of.

 

Key benefits include:

·; Enables early detection of deterioration - patients at risk can be treated sooner / improves patient safety

·; Lightweight unobtrusive wireless plaster is comfortable to wear and enables patients to be ambulatory - improves patient recovery

·; Plasters can be disposed of after use - no risk of infection transmission from one patient to another

·; Integrates well with existing clinical workflows and will be useful for generating patient early warning scores

 

About Toumaz - (www.toumazltd.com)

 

Toumaz is a pioneer in low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet connected consumer devices. The recent acquisition of Frontier Silicon brings operational scale and expertise together with a leadership position in digital and networked audio markets.

 

The Group combines its strong IP and technology base with the commercial scale of Frontier to exploit two key wireless technology sectors:

·; Professional healthcare solutions

·; Consumer semiconductors in digital audio and sport & health markets

 

Toumaz's ultra-low power sensor platform, Sensium™, targets the professional healthcare market and is a leader in real-time wireless monitoring of the body's vital signs with the potential to transform medical monitoring and reduce the cost of healthcare. SensiumVitals is the Group's first product in this field. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for personalised healthcare.

 

Toumaz plans to transfer its Sensium™ technology to the consumer sports and health market, where its advanced measurement algorithms and low energy solutions give it a competitive advantage.

 

Toumaz is also using its expertise to design devices for wireless connectivity and internet-connected The acquisition of Frontier Silicon has enhanced the Group's technology portfolio in Network Audio and elevates Toumaz to a market leadership position in this and the digital radio markets. The Group now supplies multimedia/FM/DAB chips and modules to all major audio brands.

 

Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford and Cambridge in the UK and in Hong Kong and in Shenzhen in the People's Republic of China.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMBBRTMBTJBIT
Date   Source Headline
25th Sep 20177:00 amRNSChange of Adviser
21st Sep 20175:25 pmRNSNotification of Major Interest in Shares
8th Sep 20177:00 amRNSNotice of Results
1st Aug 20172:55 pmRNSTotal Voting Rights
27th Jul 20177:00 amRNSHalf Year Trading Update
30th Jun 20177:00 amRNSTotal Voting Rights
28th Jun 20174:41 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Jun 20174:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Jun 20172:45 pmRNSTotal Voting Rights
11th May 20173:30 pmRNSTR1: Notification of Major Interest in Shares
9th May 20179:48 amRNSResult of AGM
9th May 20177:00 amRNSNotification re discontinued business
5th May 20177:00 amRNSTrading update
10th Apr 20177:00 amRNSFrontier Silicon launches miniaturised DAB+ module
5th Apr 20177:00 amRNSBlock listing Interim Review
4th Apr 20173:10 pmRNSPosting of Annual Report and Notice of AGM
3rd Apr 20177:00 amRNSDesign win for Zound Industries 'Urban Ears'
24th Mar 20177:00 amRNSFinal Results
17th Mar 20175:10 pmRNSChange in ISIN
15th Mar 20177:00 amRNSMultiple design wins
3rd Mar 20177:00 amRNSNotice of Preliminary Results
7th Feb 20177:00 amRNSDirector Dealings and Grant of Options
26th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSAppointment of Non-Executive Director
25th Nov 201612:55 pmRNSTotal Voting Rights
1st Nov 20169:30 amRNSResult of EGM
7th Oct 20167:30 amRNSPosting of Circular & Notice of EGM
27th Sep 20167:00 amRNSInterim Results
14th Sep 20167:00 amRNSNotice of Results
13th Sep 20161:45 pmRNSTotal Voting Rights
2nd Sep 20167:00 amRNSDesign Win with World's Largest Speaker Company
29th Jul 20163:10 pmRNSDirectorate Change
22nd Jul 20167:00 amRNSSale of Healthcare division and trading update
26th May 201611:00 amRNSTotal Voting Rights
17th May 201610:38 amRNSResult of AGM
31st Mar 20161:01 pmRNSTotal Voting Rights
22nd Mar 20167:00 amRNSFull year results
18th Mar 20161:07 pmRNSBlock Listing Update
7th Mar 201612:01 pmRNSNotice of Results
29th Feb 20163:17 pmRNSTotal Voting Rights
25th Feb 20163:11 pmRNSHolding(s) in Company
22nd Feb 20164:07 pmRNSHolding(s) in Company
19th Feb 20163:51 pmRNSImagination Technologies Group plc stake
8th Feb 20164:11 pmRNSDirectorate Change
21st Jan 20167:00 amRNSYear-end trading update
20th Oct 20157:00 amRNSNew £5m banking facility
1st Oct 20157:00 amRNSFrontier Silicon powers ROBERTS R-Line audio range
30th Sep 20158:00 amRNSAmendment to terms of Director's share options
29th Sep 20157:00 amRNSHalf year results
24th Sep 20151:04 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.